Widespread adoption of MPS technology for basic biomedical research, drug discovery, development and preclinical trials has resulted in a rapid proliferation of experimental models. Selection and implementation of the optimal model requires a single, powerful analytical platform to efficiently turn experimental data into reproducible, actionable information and knowledge.
The BioSystics Analytics Platform (BioSystics-AP™) is a platform for accessing, managing, analyzing, sharing, and computationally modeling complex data sets. The BioSystics-AP™ links to external databases to provide information on drugs, assays, preclinical and clinical data for model design, study design and to develop computational models. Computational modeling of multiscale data permits a better understanding of mechanisms of disease progression and compound ADME-TOX, as well as exploration of therapeutic strategies. As a centralized resource, the BioSystics-AP facilitates sharing data within a lab, with collaborators, or with the research community.